Disclosed herein are compounds of Formula (I) that are useful as inhibitors of Bruton's tyrosine kinase: where R6-R10 are as defined herein. Also disclosed are pharmaceutical compositions that include the compounds. The compounds may be used, for example, to treat autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions.